Long-Acting Lipoglycopeptides
General Principles
Long-acting lipoglycopeptides are bactericidal antibiotics that inhibit bacterial cell wall biosynthesis, similar to vancomycin. Their spectrum of activity includes gram-positive aerobic pathogens only. These agents are characterized by extremely long terminal half-lives and are currently FDA-approved for skin/soft tissue infections.
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Bhat, Pavat, et al., editors. "Long-Acting Lipoglycopeptides." Washington Manual of Medical Therapeutics, 35th ed., Wolters Kluwer Health, 2016. The Washington Manual, www.unboundmedicine.com/washingtonmanual/view/Washington-Manual-of-Medical-Therapeutics/602833/all/Long_Acting_Lipoglycopeptides.
Long-Acting Lipoglycopeptides. In: Bhat PP, Dretler AA, Gdowski MM, et al, eds. Washington Manual of Medical Therapeutics. Wolters Kluwer Health; 2016. https://www.unboundmedicine.com/washingtonmanual/view/Washington-Manual-of-Medical-Therapeutics/602833/all/Long_Acting_Lipoglycopeptides. Accessed June 1, 2023.
Long-Acting Lipoglycopeptides. (2016). In Bhat, P., Dretler, A., Gdowski, M., Ramgopal, R., & Williams, D. (Eds.), Washington Manual of Medical Therapeutics (35th ed.). Wolters Kluwer Health. https://www.unboundmedicine.com/washingtonmanual/view/Washington-Manual-of-Medical-Therapeutics/602833/all/Long_Acting_Lipoglycopeptides
Long-Acting Lipoglycopeptides [Internet]. In: Bhat PP, Dretler AA, Gdowski MM, Ramgopal RR, Williams DD, editors. Washington Manual of Medical Therapeutics. Wolters Kluwer Health; 2016. [cited 2023 June 01]. Available from: https://www.unboundmedicine.com/washingtonmanual/view/Washington-Manual-of-Medical-Therapeutics/602833/all/Long_Acting_Lipoglycopeptides.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Long-Acting Lipoglycopeptides
ID - 602833
ED - Williams,Dominique,
ED - Bhat,Pavat,
ED - Dretler,Alexandra,
ED - Gdowski,Mark,
ED - Ramgopal,Rajeev,
BT - Washington Manual of Medical Therapeutics
UR - https://www.unboundmedicine.com/washingtonmanual/view/Washington-Manual-of-Medical-Therapeutics/602833/all/Long_Acting_Lipoglycopeptides
PB - Wolters Kluwer Health
ET - 35
DB - The Washington Manual
DP - Unbound Medicine
ER -